 The Food and Drug Administration has received requests from the public to provide updated product information for estrogen and progestin-containing drug products used for treating postmenopausal symptoms. Information from the Women’s Health Initiative (WHI) trial about estrogens and progestin continues to have significant public health implications for postmenopausal women. As the series of new study results from the WHI become available, we are encouraging manufacturers to update their labels for estrogen and progestin-containing drug products for postmenopausal women to include new information from these studies. This information will allow individuals to understand the risks and benefits of these products and make appropriate health care decisions. HRT is medication containing one or more female hormones, commonly estrogen plus progestin (synthetic progesterone). Some women received estrogen-only therapy (usually women who have had their uterus removed).
HRT is most often used to treat symptoms of menopause such as “hot flashes,” vaginal dryness, mood swings, sleep disorders and decreased sexual desire.
If you or a loved one have taken Hormone Replacement Therapy and are concerned with your legal rights, please contact us to be connected with one of our HRT attorneys immediately, for a confidential consultation. |